Please log in to view this page
Username
Password
A5361s is a prospective study to determine the effects of pitavastatin on physical function. The study will enroll participants...
This study will compare the efficacy and safety of 26 weeks of delamanid (DLM) versus 26 weeks of isoniazid (INH) for preventing...
HPTN 069 is a phase II, four-arm, multisite, randomized, double-blinded trial. To assess the safety and tolerability of four...
The purpose of this study is to evaluate the safety, tolerability, and effect of an experimental human monoclonal antibody...
REPRIEVE (A5332) is a large double-blind, randomized, placebo-controlled study of pitavastatin or placebo for about 72 months....
